Science news in review: Sept. 10

Welcome back to another academic year! Let’s kick things off with the latest updates on science and technology, which include a closer look at how carbon monoxide slips off hemoglobin, a promising method for earlier ALS detection and Amazon joining the AI agent race.

Hemoglobin’s hidden exit: a new understanding for CO escape

Hemoglobin is a crucial protein that keeps us alive, carrying oxygen from our lungs to tissues all over our bodies. Carbon monoxide (CO) is a gas that can bind to hemoglobin approximately 200 to 300 times stronger than oxygen can. Its strong binding ability causes it to not only stop oxygen from binding to hemoglobin but also change the shape of the hemoglobin protein — this is called carbon monoxide poisoning. 

Once bound, CO is slow to come off without assistance, but there are several induced ways CO unbinds, too. The original view was that CO detaches from hemoglobin in a single fast step, but new research has discovered two distinct steps, an initial detachment and then a total release, which are picoseconds — or one trillionth of a second — apart. To put that into perspective, the mechanism could occur almost one hundred billion times in the time it takes for humans to blink once.

Understanding the detachment pathway of CO from hemoglobin could potentially foster research for protein-ligand interactions, which is important because many diseases, including sickle cell disease and thalassemia, involve problems with protein binding or ligand release. 

Researchers discovered that when CO detaches from hemoglobin, it doesn’t always leave immediately. In some cases, it lingers inside the protein in intermediate states. Using advanced infrared spectroscopy, which is able to detect events to the quadrillionth of a second, researchers were able to observe and document this process for the first time. They also found that shifts in the protein’s shape may be what triggers the gas to fully escape. This is significant because it provides clear evidence to the complexity of protein behavior, and it could explain how oxygen and carbon monoxide dynamically interact with the body’s most important oxygen-carrying molecules.

Ultimately, this discovery deeply enhances understanding of protein-ligand dynamics and could potentially inform the development of drugs targeting proteins like hemoglobin or methods to block harmful binding to proteins in the human body. It’s a discovery made in the lab with big future potential.

ALS detection transformed: protein signatures reveal disease years early

Amyotrophic lateral sclerosis (ALS) is a degenerative nervous system disease that damages nerve cells in charge of controlling voluntary muscle movement, resulting in muscle weakness and difficulty breathing. As of now, ALS diagnosis is based on neurological evaluations and detection of symptoms. In other words, there is no specific and accurate diagnostic test for ALS.

It was previously assumed that ALS developed within 1-2 years before symptoms appeared, but new discoveries suggest inaccuracies in that assumption. Researchers at the School of Medicine successfully found a set of proteins that can detect ALS years before symptoms appear by examining blood samples of patients with active ALS and donated pre-ALS blood samples. The identified protein signatures, researchers note, were not because of inherited genetic mutations but were specifically linked to biomarkers of ALS. Researchers specified that the model could minimize potential false positive diagnoses of other neurological diseases, such as Parkinson’s and neuropathy.

This finding opens doors for preclinical research on patients found with the protein signature, and early intervention before the nervous system is significantly damaged. Additionally, the discovery allows early awareness, which gives patients and families more time to prepare, seek support resources and make medical decisions. This research could spark new ways to treat ALS earlier, shifting the focus from just mitigating symptoms to stopping the disease in its pre-symptom tracks.

Amazon bets on AI

Internal sources reveal Amazon’s intentions to enter the AI agent race with a new workplace software suite called Quick Suite. The company is currently in a private preview phase and has initiated beta-testing, inviting internal departments and other companies to try implementing the software in their work.

Amazon, in its beta test invitation, wrote: “With over 40% of business users expected to adopt AI-enhanced work environments soon, Amazon Web Services (AWS) is positioned to lead this shift by providing integrated solutions that help organizations – including our own – effectively deploy and scale AI agents in the workplace.”

Amazon’s Quick Suite is a software package integrating existing AWS tools for data visualization and the current AI chatbot with a new component, Quick Flows, for automating workflows such as data processing, report generation and customer support tasks. The efficacy of Quick Suite has been acknowledged by companies including BMW and Koch Industries, who have adopted the software into their systems. Quick Suite, being designed to help businesses make better and faster decisions, highlights workflow support, enterprise security protection and user friendly interfaces. At the same time, some of the feedback received from the beta testing process reported problems including strict permission requirements for data connections and cloud restrictions.

There has been no public timeline for the release of Amazon’s new AI agent, but the expected outcome implies Amazon’s place as a direct competitor with Google, Microsoft, OpenAI and other corporations developing tools resembling Quick Suite. Amazon’s Quick Suite can also be seen as a bold move to assert dominance in the software-as-a-service market, which refers to cloud-based softwares that users can access over the internet through subscriptions instead of installation. This market, with popular services like Zoom and Google Workspace, has grown rapidly in the past years due to its lower costs, automatic updates and easy scaling for business. Through this new service, Amazon reinforces its place as one of the leaders in software and paves the way for more exciting developments in AI to come.


Continue Reading